333 related articles for article (PubMed ID: 38578405)
21. Drug delivery approaches for the treatment of glioblastoma multiforme.
Fakhoury M
Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1365-73. PubMed ID: 26046399
[TBL] [Abstract][Full Text] [Related]
22. Targeting glioblastoma through nano- and micro-particle-mediated immune modulation.
Poot E; Maguregui A; Brunton VG; Sieger D; Hulme AN
Bioorg Med Chem; 2022 Oct; 72():116913. PubMed ID: 36007293
[TBL] [Abstract][Full Text] [Related]
23. Translation of focused ultrasound for blood-brain barrier opening in glioma.
Brighi C; Salimova E; de Veer M; Puttick S; Egan G
J Control Release; 2022 May; 345():443-463. PubMed ID: 35337938
[TBL] [Abstract][Full Text] [Related]
24. Novel delivery methods bypassing the blood-brain and blood-tumor barriers.
Hendricks BK; Cohen-Gadol AA; Miller JC
Neurosurg Focus; 2015 Mar; 38(3):E10. PubMed ID: 25727219
[TBL] [Abstract][Full Text] [Related]
25. Current Challenges and Opportunities in Treating Glioblastoma.
Shergalis A; Bankhead A; Luesakul U; Muangsin N; Neamati N
Pharmacol Rev; 2018 Jul; 70(3):412-445. PubMed ID: 29669750
[TBL] [Abstract][Full Text] [Related]
26. Stimuli-Responsive Multifunctional Nanomedicine for Enhanced Glioblastoma Chemotherapy Augments Multistage Blood-to-Brain Trafficking and Tumor Targeting.
Martins C; Araújo M; Malfanti A; Pacheco C; Smith SJ; Ucakar B; Rahman R; Aylott JW; Préat V; Sarmento B
Small; 2023 Jun; 19(22):e2300029. PubMed ID: 36852650
[TBL] [Abstract][Full Text] [Related]
27. Blood-Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade.
Virtanen PS; Ortiz KJ; Patel A; Blocher WA; Richardson AM
Curr Oncol Rep; 2024 Mar; 26(3):236-249. PubMed ID: 38329660
[TBL] [Abstract][Full Text] [Related]
28. Breaching barriers in glioblastoma. Part II: Targeted drug delivery and lipid nanoparticles.
Miranda A; Blanco-Prieto MJ; Sousa J; Pais A; Vitorino C
Int J Pharm; 2017 Oct; 531(1):389-410. PubMed ID: 28801108
[TBL] [Abstract][Full Text] [Related]
29. Drug Repurposing for Glioblastoma and Current Advances in Drug Delivery-A Comprehensive Review of the Literature.
Alomari S; Zhang I; Hernandez A; Kraft CY; Raj D; Kedda J; Tyler B
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944514
[TBL] [Abstract][Full Text] [Related]
30. Convection-enhanced delivery for glioblastoma: targeted delivery of antitumor therapeutics.
Ung TH; Malone H; Canoll P; Bruce JN
CNS Oncol; 2015; 4(4):225-34. PubMed ID: 26103989
[TBL] [Abstract][Full Text] [Related]
31. Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials.
Bruinsmann FA; Richter Vaz G; de Cristo Soares Alves A; Aguirre T; Raffin Pohlmann A; Stanisçuaski Guterres S; Sonvico F
Molecules; 2019 Nov; 24(23):. PubMed ID: 31779126
[TBL] [Abstract][Full Text] [Related]
32. Frontiers in the treatment of glioblastoma: Past, present and emerging.
Janjua TI; Rewatkar P; Ahmed-Cox A; Saeed I; Mansfeld FM; Kulshreshtha R; Kumeria T; Ziegler DS; Kavallaris M; Mazzieri R; Popat A
Adv Drug Deliv Rev; 2021 Apr; 171():108-138. PubMed ID: 33486006
[TBL] [Abstract][Full Text] [Related]
33. Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment.
Pandey N; Anastasiadis P; Carney CP; Kanvinde PP; Woodworth GF; Winkles JA; Kim AJ
Adv Drug Deliv Rev; 2022 Sep; 188():114415. PubMed ID: 35787387
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic Delivery to Central Nervous System.
Kunigelis KE; Vogelbaum MA
Neurosurg Clin N Am; 2021 Apr; 32(2):291-303. PubMed ID: 33781509
[TBL] [Abstract][Full Text] [Related]
35. Intraarterial drug delivery for glioblastoma mutiforme: Will the phoenix rise again?
Joshi S; Ellis JA; Ornstein E; Bruce JN
J Neurooncol; 2015 Sep; 124(3):333-43. PubMed ID: 26108656
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of Therapies for Glioblastoma (GBM) Using Nanoparticle-based Delivery Systems.
Wiwatchaitawee K; Quarterman JC; Geary SM; Salem AK
AAPS PharmSciTech; 2021 Feb; 22(2):71. PubMed ID: 33575970
[TBL] [Abstract][Full Text] [Related]
37. Use of nanoparticles for drug delivery in glioblastoma multiforme.
Jain KK
Expert Rev Neurother; 2007 Apr; 7(4):363-72. PubMed ID: 17425491
[TBL] [Abstract][Full Text] [Related]
38. Molecular Mechanisms of Treatment Resistance in Glioblastoma.
Ou A; Yung WKA; Majd N
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396284
[TBL] [Abstract][Full Text] [Related]
39. Advances in drug delivery technology for the treatment of glioblastoma multiforme.
Cha GD; Kang T; Baik S; Kim D; Choi SH; Hyeon T; Kim DH
J Control Release; 2020 Dec; 328():350-367. PubMed ID: 32896613
[TBL] [Abstract][Full Text] [Related]
40. Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds.
Asija S; Chatterjee A; Yadav S; Chekuri G; Karulkar A; Jaiswal AK; Goda JS; Purwar R
Int Rev Immunol; 2022; 41(6):582-605. PubMed ID: 35938932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
